Regeneron Pharmaceuticals, Inc.
REGN
$769.68
$3.020.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.15% | 4.92% | 72.08% | -11.88% | -31.55% |
| Total Depreciation and Amortization | 6.07% | 1.18% | 6.46% | 0.40% | 3.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 129.05% | -290.54% | -668.16% | -106.59% | 384.61% |
| Change in Net Operating Assets | -99.06% | 374.24% | -275.85% | 250.00% | -35.21% |
| Cash from Operations | -27.68% | 41.45% | 9.50% | -17.24% | -2.20% |
| Capital Expenditure | -23.49% | 8.04% | 4.49% | -14.88% | 17.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 90.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 336.42% | 77.31% | -199.79% | 56.10% | 268.93% |
| Cash from Investing | 154.68% | 63.17% | -268.96% | 84.68% | 161.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,149.38% | 27.94% | -48.02% | -33.33% | -64.31% |
| Repurchase of Common Stock | -78.55% | 37.49% | -2.05% | 14.73% | -43.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.64% | 1.51% | 1.28% | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | -8.66% | 36.37% | -3.58% | 4.08% | -79.10% |
| Foreign Exchange rate Adjustments | 25.00% | -200.00% | -33.33% | 185.71% | -187.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.73% | 146.18% | -278.38% | 26.57% | 470.81% |